Get the Stockscreener App
1.07
0.00%
0.00
Enlivex Therapeutics Ltd Stock (ENLV) Forecast
The Enlivex Therapeutics Ltd (ENLV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.856, representing a +73.46% increase from the current price of $1.07. The highest analyst price target is $1.7731, and the lowest is $1.9389.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ENLV Price Target
Average 12.05
(+1,026% Upside)
Is Enlivex Therapeutics Ltd (ENLV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.35 | Neutral |
| STOCH(9,6) | 45.56 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.066 | Buy |
| ADX(14) | 14.01 | Neutral |
| William %R | -46.15 | Neutral |
| CCI(14) | 4.67 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.0525
Buy
|
1.0662
Buy
|
| MA20 |
1.1058
Sell
|
1.1183
Sell
|
| MA50 |
1.2416
Sell
|
1.1719
Sell
|
| MA100 |
1.1301
Sell
|
1.1584
Sell
|
| MA200 |
1.1154
Sell
|
1.1748
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, ENLV could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 9 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ENLV, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.35 indicates that ENLV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 45.56 indicates that ENLV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that ENLV is oversold. This suggests that ENLV price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.01 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 4.67 indicates that ENLV is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ENLV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Enlivex Therapeutics Ltd financial reports and earnings history, Enlivex Therapeutics Ltd (ENLV) stock could reach $5.9544 by 2030, $5.9479 by 2040 and $18.45 by 2050. See the projected annual prices until 2050 of the Enlivex Therapeutics Ltd stock below:
- Enlivex Therapeutics Ltd (ENLV) is expected to reach an average price of $2.2532 in 2035, with a high prediction of $3.0307 and a low estimate of $2.5132. This indicates an $110.58% rise from the last recorded price of $1.07.
- Enlivex Therapeutics Ltd (ENLV) stock is projected to chart a bullish course in 2040, with an average price target of $6.0801, representing an $468.23% surge from its current level. The forecast ranges from a conservative $6.1852 to a sky-high $5.9479.
- Our analysts predict Enlivex Therapeutics Ltd (ENLV) to jump 933.34% by 2045, soaring from $10.83 to an average price of $11.06, potentially reaching $10.79. While $10.83 is the low estimate, the potential upside is significant.
- Enlivex Therapeutics Ltd (ENLV) stock is expected to climb by 2050, reaching an average of $18.06, a $1,588% jump from its current level. However, a wide range of estimates exists, with high and low targets of $18.45 and $18.47, respectively, highlighting the market's uncertainty.
Enlivex Therapeutics Ltd Stock (ENLV) Year by Year Forecast
Enlivex Therapeutics Ltd Stock (ENLV) Price Forecast for 2025
Enlivex Therapeutics Ltd Stock (ENLV) is expected to reach an average price of $4.585 in 2025, with a high prediction of $9.143 and a low estimate of $0.027. This indicates an +328.50% rise from the last recorded price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2025 | $2.0231 | $1.9389 | $1.7731 | +89.07% |
| November, 2025 | $0.9594 | $1.8412 | $1.8672 | -10.34% |
| December, 2025 | $4.2803 | $1.0466 | $8.1625 | +300.03% |
Enlivex Therapeutics Ltd Stock (ENLV) Price Forecast for 2026
The predicted value for Enlivex Therapeutics Ltd (ENLV) in 2026 is set at an average of $12.15. Estimates vary from a peak of $23.06 to a trough of $1.2419, indicating an +1,035% surge from the present price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.964 | $1.2419 | $5.6662 | +83.56% |
| February, 2026 | $4.3478 | $1.4259 | $7.1659 | +306.33% |
| March, 2026 | $4.0415 | $1.7696 | $4.813 | +277.71% |
| April, 2026 | $11.59 | $4.2474 | $23.06 | +983.29% |
| May, 2026 | $7.3149 | $5.103 | $12.20 | +583.64% |
| June, 2026 | $5.6087 | $3.9768 | $7.6209 | +424.17% |
| July, 2026 | $3.4083 | $2.3183 | $6.4665 | +218.53% |
| August, 2026 | $3.6721 | $3.1521 | $4.3743 | +243.18% |
| September, 2026 | $2.4317 | $1.6317 | $4.268 | +127.26% |
| October, 2026 | $2.6255 | $1.5036 | $3.5055 | +145.37% |
| November, 2026 | $8.3192 | $2.9414 | $8.4092 | +677.49% |
| December, 2026 | $4.2999 | $4.2889 | $8.1851 | +301.86% |
Enlivex Therapeutics Ltd Stock (ENLV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Enlivex Therapeutics Ltd (ENLV) is $2.3322, with a high forecast of $4.6548 and a low forecast of $0.00962. This indicates an +117.96% increase from the last price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.2026 | $2.8426 | $4.6548 | +199.31% |
| February, 2027 | $2.7663 | $2.5263 | $4.1145 | +158.54% |
| March, 2027 | $1.196 | $0.7861 | $2.7323 | +11.78% |
| April, 2027 | $0.8997 | $0.6079 | $1.8301 | -15.91% |
| May, 2027 | $0.0835 | $0.0675 | $1.1057 | -92.20% |
| June, 2027 | $0.2131 | $0.0294 | $0.7273 | -80.08% |
| July, 2027 | $0.9569 | $0.1291 | $1.0969 | -10.57% |
| August, 2027 | $2.1506 | $0.8928 | $4.0587 | +100.99% |
| September, 2027 | $0.3203 | $0.4897 | $1.9883 | -70.07% |
| October, 2027 | $0.306 | $0.1219 | $1.1022 | -71.40% |
| November, 2027 | $1.4078 | $0.0878 | $1.4878 | +31.57% |
| December, 2027 | $1.0274 | $0.00962 | $1.3537 | -3.98% |
Enlivex Therapeutics Ltd Stock (ENLV) Price Forecast for 2028
In 2028, Enlivex Therapeutics Ltd (ENLV) is projected to reach an average price of $1.1087, with a high projection of $2.1393 and a low estimate of $0.0782. This indicates an +3.62% rise from the last price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.2012 | $0.7593 | $2.1393 | +12.26% |
| February, 2028 | $0.3949 | $0.229 | $1.533 | -63.09% |
| March, 2028 | $0.5646 | $0.1268 | $0.7007 | -47.24% |
| April, 2028 | $1.0383 | $0.3864 | $1.2724 | -2.96% |
| May, 2028 | $0.398 | $0.318 | $1.2542 | -62.81% |
| June, 2028 | $0.7617 | $0.1539 | $1.0358 | -28.81% |
| July, 2028 | $1.0654 | $0.7276 | $1.3653 | -0.43% |
| August, 2028 | $0.4751 | $0.4751 | $1.0915 | -55.60% |
| September, 2028 | $0.1912 | $0.2829 | $0.7488 | -82.13% |
| October, 2028 | $0.2074 | $0.1866 | $0.1748 | -80.61% |
| November, 2028 | $0.1728 | $0.1914 | $0.2065 | -83.85% |
| December, 2028 | $0.0867 | $0.0782 | $0.2041 | -91.90% |
Enlivex Therapeutics Ltd Stock (ENLV) Price Forecast for 2029
The 2029 price forecast for Enlivex Therapeutics Ltd Stock (ENLV) is $3.0912 on average, with a high prediction of $6.17 and a low estimate of $0.0125. This represents an +188.90% increase from the previous price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0244 | $0.1544 | $0.1917 | -97.72% |
| February, 2029 | $0.1006 | $0.0125 | $0.5916 | -90.60% |
| March, 2029 | $0.4869 | $0.1587 | $0.0872 | -54.50% |
| April, 2029 | $0.8631 | $0.869 | $0.7331 | -19.33% |
| May, 2029 | $0.3535 | $0.6216 | $0.8353 | -66.96% |
| June, 2029 | $0.2397 | $0.2523 | $0.3275 | -77.59% |
| July, 2029 | $0.764 | $0.3138 | $1.4181 | -28.60% |
| August, 2029 | $0.9937 | $0.6937 | $2.0499 | -7.13% |
| September, 2029 | $1.3374 | $0.7655 | $1.7974 | +24.99% |
| October, 2029 | $2.1071 | $1.1033 | $2.7711 | +96.92% |
| November, 2029 | $0.1492 | $0.1651 | $3.0689 | -86.06% |
| December, 2029 | $7.38 | $0.0527 | $6.17 | +589.72% |
Enlivex Therapeutics Ltd Stock (ENLV) Price Forecast for 2030
Enlivex Therapeutics Ltd Stock (ENLV) is expected to reach an average price of $14.06 in 2030, with a high forecast of $28.01 and a low forecast of $0.1069. This signifies an +1,214% surge from the last price of $1.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.5227 | $6.4107 | $5.9544 | +42.30% |
| February, 2030 | $5.4868 | $0.1069 | $6.4868 | +412.79% |
| March, 2030 | $5.1443 | $0.2395 | $12.04 | +380.77% |
| April, 2030 | $10.70 | $3.4811 | $11.76 | +900.16% |
| May, 2030 | $9.6711 | $8.2592 | $28.01 | +803.84% |
| June, 2030 | $8.8814 | $7.467 | $11.61 | +730.04% |
| July, 2030 | $8.5921 | $8.8521 | $9.7877 | +703.00% |
| August, 2030 | $6.4046 | $7.6846 | $7.7165 | +498.56% |
| September, 2030 | $7.4572 | $7.2528 | $7.0506 | +596.93% |
| October, 2030 | $7.4358 | $7.3134 | $7.7897 | +594.94% |
| November, 2030 | $10.71 | $7.485 | $9.2404 | +900.97% |
| December, 2030 | $10.44 | $10.73 | $10.49 | +875.97% |
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):